4//SEC Filing
Kessler Paul D. 4
Accession 0001455244-11-000013
CIK 0000072444other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 3:42 PM ET
Size
5.5 KB
Accession
0001455244-11-000013
Insider Transaction Report
Form 4
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Transactions
- Award
Stock Option (right to buy)
2010-03-15+1,000→ 1,000 totalExercise: $5.86Exp: 2017-03-15→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]The Stock Option (right to buy) is exercisable in four equal installments on March 15, 2011, March 15, 2012, March 15, 2013 and March 15, 2014.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001428524
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 3:42 PM ET
- Size
- 5.5 KB